A pilot study of streptokinase‐induced endothelial injury and platelet activation following acute myocardial infarction

作者: G. Y. H. Lip , C. Lydakis , S. L. Nuttall , M. J. Landray , R. D. S. Watson

DOI: 10.1046/J.1365-2796.2000.00738.X

关键词:

摘要: Abstract. Lip GYH, Lydakis C, Nuttall SL, Landray MJ, Watson RDS, Blann AD (Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK). A pilot study streptokinase-induced endothelial injury platelet activation following acute myocardial infarction. J Intern Med248: 316–318. Objective. To relate the changes in serum vitamin E, an essential antioxidant, to fibrinogen, as well indices damage [as indicated by plasma markers, soluble thrombomodulin (sTM) von Willebrand factor (vWf)], index [soluble P selectin (sPsel)], infarction treated with thrombolytic therapy. Design Setting. Prospective longitudinal a teaching hospital Coronary Care Unit. Subjects intervention. Seventeen patients (12 men; mean age 62 years ± SD 11 years) admitted (AMI), who were given therapy, 59 healthy controls. Results. Baseline levels fibrinogen (Mann–Whitney test, P = 0.0055) vWf (P < 0.001) significantly higher than controls, but sPsel, sTM or E not different. Following thrombolysis, expected, median concentrations fell profoundly (Friedman anovaP < 0.001) so that after 45 min, undetectable 13 patients. At 24-h concentration had recovered approximately 30% baseline (P < 0.01) was still three Levels sPsel increased steadily, reaching significance hours (both P < 0.05). However, rose immediately peaking between 1 3 h, remained elevated at 24 h. These increases corresponded simultaneous early fall concentrations. Conclusion. The present demonstrates significant association oxidative stress streptokinase therapy for AMI.

参考文章(5)
Andrew D Blann, Gregory Y.H Lip, Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis. ,vol. 128, pp. 135- 138 ,(1997) , 10.1016/S0021-9150(96)05980-1
Hans Martin Hoffmeister, Sebastian Szabo, Christof Kastner, Martin E. Beyer, Uwe Helber, Silke Kazmaier, Hans Peter Wendel, Wolfgang Heller, Ludger Seipel, Thrombolytic Therapy in Acute Myocardial Infarction Comparison of Procoagulant Effects of Streptokinase and Alteplase Regimens With Focus on the Kallikrein System and Plasmin Circulation. ,vol. 98, pp. 2527- 2533 ,(1998) , 10.1161/01.CIR.98.23.2527
Gilles Montalescot, François Philippe, Annick Ankri, Eric Vicaut, Etienne Bearez, Jean Ernest Poulard, Didier Carrie, Daniel Flammang, Albert Dutoit, Alain Carayon, Claude Jardel, Monique Chevrot, Jean Philippe Bastard, Fredérique Bigonzi, Daniel Thomas, Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease Circulation. ,vol. 98, pp. 294- 299 ,(1998) , 10.1161/01.CIR.98.4.294
SRJ Maxwell, MJ Landray, SL Nuttall, C Lydakis, U Martin, GYH Lip, Oxidative stress after thrombolysis The Lancet. ,vol. 352, pp. 960- 960 ,(1998) , 10.1016/S0140-6736(05)61514-0
ANDREW D. BLANN, DAVID A. TABERNER, A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST? British Journal of Haematology. ,vol. 90, pp. 244- 248 ,(1995) , 10.1111/J.1365-2141.1995.TB05143.X